Title for MeetingAbstracts
Alphabetical listing of titles
-
An open treatment study of acute HIV infection with zidovudine, lamivudine and indinavir sulfate.
-
An open trial of intravenous ganciclovir three times or five times a week as CMV retinitis maintenance therapy.
-
An open trial of Zidovudine (AZT) in 17 zairian patients with AIDS.
-
An open, controlled, randomized study on discontinuation of secondary prophylaxis for Pneumocystis Carinii Pneumonia in patients with AIDS.
-
An Open, Non-Comparative Multicenter Study to Evaluate Efficacy and Safety of Posaconazole (SCH 56592) in the Treatment of Invasive Fungal Infections (IFI) Refractory (R) to or Intolerant (I) to Standard Therapy (ST).
-
An open, randomised, prospective comparison of oral dapsone and nebulised pentamidine for PCP prophylaxis.
-
An Open, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of SmithKline Beecham Biologicals' Combined Hepatitis A/Hepatitis B (Twinrix[TM]) Vaccine in Adults.
-
An open, randomized, crossover study in HIV infected patients to evaluate the possible interaction between L- 697,661 and didanosine (ddI).
-
An open-label Expanded Access Program (EAP) to assess the safety of Tipranavir Co-administered with low-dose Ritonavir (TPV/r) in patients with advanced HIV-1 Infection and limited treatment options.
-
An open-label pilot study to evaluate the development of resistance to nevirapine (BI-RG-587) in HIV-infected patients with CD4 cell count > or = 500/mm. ACTG 208 Study Team.
-
An open-label randomized study of Rescriptor (DLV, delavirdine mesylate) in triple and quadruple combinations with zidovudine (ZDV), indinavir (IDV) and lamivudine (3TC) in HIV-1 infected individuals.
-
An open-label safety and pharmacokinetic study of single intravenous ascending doses of GEM 91 in untreated, adult, HIV positive, asymptomatic human volunteer patients.
-
An Open-Label Steady State Investigation of the Pharmacokinetics (PK) of Tipranavir (TPV) and Ritonavir (RTV) and their Effects on Cytochrome P-450 (3A4) Activity in Normal Healthy Volunteers (BI 1182.5).
-
An open-label study of the safety and efficacy of co-administration of Zidovudine and recombinant ifn-beta.
-
An open-label study to evaluate safety and efficacy of Combivir, Abacavir, Efavirenz in antiretroviral therapy naive adults (La Francilienne).
-
An Open-Label, Multicenter Study of the Efficacy and Safety of Peginterferon alfa-2a (40KD) (PEGASYS), Alone, or in Combination with Ribavirin (COPEGUS), in Patients with HIV/HCV Co-Infection.
-
An Open-Label, Multicenter, Non-Comparative Study of Oral Bms-284756 in the Treatment of Community Acquired Pneumonia (CAP).
-
An open-label, randomized, comparative study of d4T + 3TC + IDV versus ZDV + 3TC + IDV in treatment naive HIV-infected patients (START I).
-
An open-label, randomized, comparative study of d4T + ddI + IDV versus ZDV + 3TC + IDV in treatment naive HIV infected patients.
-
An open-label, randomized, comparative study of d4T + ddI + IDV versus ZDV + 3TC + IDV in treatment naive HIV-infected patients (START II).
-
An open-label, randomized, comparative study of d4T+ 3TC + IDV versus ZDV + 3TC + IDV in treatment naive HIV-infected patients.
-
An Open-Label, Randomized, Comparative Study of Stavudine (d4T) + Lamivudine (3TC) + Indinavir (IDV) Versus Zidovudine (ZDV) + 3TC + IDV in Treatment of HIV-Infected Patients: START I.
-
An opening day information to prevent AIDS.
-
An opportunity lost: estimating the number of HIV infections due to the U.S. failure to adopt a national needle exchange policy.
-
An Opsonic Antibody Inhibition Assay Detects Functional Differences among Pneumococcal Capsular Polysaccharides Used in Vaccine Formulations.
-
An optimized measure of human adaptation to simulated weightlessness.
-
An option for living together.
-
An oral phase I/II study of 2-fluoro dideoxycytidine (2FddC) in previously untreated HIV-infected patients (ANRS 012).
-
An Orally Bioavailable CXCR4 Antagonist for Inhibition of HIV Replication.
-
An organ model for HIV infection of the blood brain barrier.